EC
Elvia Cowan
SVP, Finance & CAO

Elvia Cowan insider trades: Vaxcyte (PCVX) stock sales

SVP, Finance & CAO, Vaxcyte Last trade Nov 2, 2026 19 Form 4 filings
$2.3M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Elvia reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026PCVX↓ Sell$183K
Oct 5, 2026PCVX↓ Sell$1.6M
Apr 7, 2026PCVX↓ Sell$180K
Mar 17, 2026PCVX↓ Sell$105K
Mar 11, 2026PCVX↓ Sell$146K
Sep 3, 2024PCVX↓ Sell$538K
Jul 16, 2024PCVX↓ Sell$425K
Jul 8, 2024PCVX↓ Sell$400K
Mar 1, 2024PCVX↓ Sell$865K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PCVX insiders

Open-market trades in the last 12 months

About Elvia Cowan's insider trades

Elvia Cowan is SVP, Finance & CAO at Vaxcyte (PCVX). Since Mar 1, 2024, Elvia has reported no open-market purchases and 9 sales worth $4.5M on SEC Form 4. In the last 12 months: 5 sales ($2.3M).

Their filings also include option exercises (10 filings), shares withheld for taxes (9 filings), grants and awards (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.